Clinical trials recruiting for Vascular Diseases
18
Recruiting trials
32
US states with sites
11
Countries
17%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Phase 4 1Not applicable 15
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Low-dose aspirin | 1 |
| Mosliciguat | 1 |
| inhaled mosliciguat | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Michigan | 5 |
| Florida | 4 |
| Massachusetts | 4 |
| California | 3 |
| Illinois | 3 |
| Louisiana | 3 |
| North Carolina | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Georgia | 2 |
| Kansas | 2 |
| Minnesota | 2 |
Top cities
Boston, Massachusetts 4Detroit, Michigan 4Chapel Hill, North Carolina 2Charleston, South Carolina 2Chicago, Illinois 2Dallas, Texas 2Kissimmee, Florida 2Albany, New York 1Albuquerque, New Mexico 1Ann Arbor, Michigan 1
Self-screener
Recruiting trials
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
- Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
- Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
- Diabetic Neuropathy in Spinal Cord Stimulator Patients
- Global Paradise System US Post Approval Study
- Hamburg City Health Study - a German Cohort Study
- Hypertension Explored in Long-term Postpartum Follow-up in Later Life
- Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
- Mechanisms of Pregnancy Vascular Adaptations
- SPYRAL GEMINI Pilot Study
- Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Spyral InSight Study
- Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- The RADIANCE CED Study
- Treatment With Aspirin After Preeclampsia: TAP Trial
Related conditions
Trials recruiting for Vascular Diseases often also study these conditions. Each links to its own recruiting-trial list.
Cardiovascular Diseases 164Hypertension 1201Diabetes Mellitus 71Pulmonary hypertension 95Type 2 diabetes 891Stroke 94Pre-Eclampsia 32Ischemia 3Heart failure 1021Heart Diseases 26
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Vascular Diseases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.